Group
|
Instrument
|
Mean change
|
SD of mean change
|
95% CI of mean change
|
Pooled SD
|
ES
|
Reliability
|
d
|
Required sample size
a
|
---|
aMCI | | | | | | | | | |
| AQ | 1.66 | 4.96 | (0.40, 2.92) | 6.10 | 0.27 | 0.65 | 0.33 | 251 |
| FAQ | 2.05 | 5.79 | (0.54, 3.56) | 3.29 | 0.30 | 0.63 | 0.35 | 224 |
| MMSE | -0.55 | 2.54 | (-1.19, 0.10) | 2.47 | 0.22 | 0.56 | 0.24 | 597 |
AD | | | | | | | | | |
| AQ | 2.49 | 4.77 | (0.94, 4.03) | 6.75 | 0.37 | 0.64 | 0.43 | 232 |
| FAQ | 3.59 | 4.91 | (2.00, 5.18) | 5.36 | 0.52 | 0.81 | 0.84 | 119 |
| MMSE | -2.13 | 3.35 | (-3.23, -1.03) | 6.34 | 0.34 | 0.79 | 0.52 | 157 |
CN | | | | | | | | | |
| AQ | 0.47 | 2.73 | (-0.07, 1.00) | 3.37 | 0.14 | 0.69 | 0.18 | 340 |
| FAQ | 0.33 | 1.80 | (-0.03, 0.69) | 3.29 | 0.11 | 0.73 | 0.15 | 300 |
| MMSE | 0.05 | 1.71 | (-0.29, 0.39) | 2.47 | 0.02 | 0.41 | 0.02 | 660 |
-
aNumber of subjects per arm based on a 25% treatment effect of the mean change at 80% power with a two-tailed significance level of 0.05; sample size estimates are based on a two-year study for AD, a three-year study for aMCI, and five-year study for CN; for AQ and FAQ positive mean change scores represent increased impairment over time and negative mean change scores for MMSE also represent increased impairment over time. Effect size values are reported in absolute values and represent the magnitude of the difference for Year 2 scores subtracted from Year 1 scores. AD, Alzheimer’s disease; aMCI, amnestic mild cognitive impairment; AQ, Alzheimer’s Questionnaire; 95% CI, 95% confidence interval; CN, cognitively normal; d, effect size corrected for reliability; ES; effect size using pooled standard deviation; FAQ, Functional Activities Questionnaire; MMSE, Mini Mental State Exam; SD, standard deviation.